European Pharmaceutical Review

OCTOBER 6, 2023

Positive interim results from Moderna’s Phase I/II trial of mRNA-1083 , an investigational vaccine designed to immunise against both influenza and COVID-19, have been released. There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

The Guardian - Pharmaceutical Industry

AUGUST 14, 2024

Chancellor reportedly seeking to cut £20m from the £65m promised by Hunt to Merseyside manufacturing plant Business live – latest updates A £450m plan to expand an AstraZeneca vaccine-manufacturing site in Merseyside has suffered a blow after it emerged the government plans to cut some of the funding for the scheme. Continue reading.

Vaccines 89

Vaccines Pharmaceutical Companies Pharmaceutical Companies 89

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 97

STAT

AUGUST 17, 2023

A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

STAT

AUGUST 22, 2023

The Food and Drug Administration approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people, STAT tells us. The vaccine, marketed as Abrysvo, previously won approval for adults over the age of 60.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 98

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccines 96

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 96

Pharmafile

MAY 9, 2024

UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria due to a drop in global demand. The withdrawal also comes after AstraZeneca admitted in court documents that the vaccine can cause thrombosis with thrombocytopenia syndrome (TTS).

Vaccines 59

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 59

The Guardian - Pharmaceutical Industry

JANUARY 27, 2025

Collaboration over at least three years aims to help understand how pre-cancerous cells develop Business live latest updates GSK has said it will spend 50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers. Continue reading.

Vaccines 63

Vaccines Pharmaceutical Companies Pharmaceutical Companies 63

European Pharmaceutical Review

AUGUST 31, 2023

Even with extremely rapid vaccine development, limitations in production capabilities can have real-life implications. This has led pharmaceutical equipment manufacturers to react quickly, while maintaining due levels of diligence and social responsibility.

Vaccines 104

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 104

European Pharmaceutical Review

FEBRUARY 10, 2025

AstraZeneca has scrapped its planned 450 million expansion of a vaccine manufacturing facility in Liverpool, UK, citing economic factors and reduced government funding. The post AstraZeneca cancels 450m Liverpool vaccine facility expansion appeared first on European Pharmaceutical Review.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Mirror

SEPTEMBER 11, 2022

Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 25, 2023

As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.

Vaccines 69

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 69

Pharma Times

OCTOBER 1, 2021

The European Patent Office (EPO) has granted a patent to specialist pharmaceutical company, N4 Pharma, for its Nuvec cancer treatment and vaccine delivery system.

Vaccines 49

Vaccines Pharmaceutical Companies Pharmaceutical Companies 49

pharmaphorum

APRIL 8, 2020

This pharmaphorum webinar will take place on 8th April and comes as the COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus vaccine. So, what is technology’s role in supporting the faster evaluation of vaccines?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 21, 2022

The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this. The result of the improving knowledge of vaccines’ role in society initially led to a rise in interest in receiving a COVID-19 vaccine.

Vaccines 98

Vaccines Immunization Compounding Pharmaceutical Companies 98

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Coronavirus vaccine components. The vaccine also contains other inactive ingredients such as cholesterol.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunization 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Flavivirus vaccine components. Sanofi is one of the leading patent filers for Flavivirus vaccine components.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunization 52

Pharmaceutical Technology

MARCH 9, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Multivalent veterinary vaccines. However, not all innovations are equal and nor do they follow a constant upward trend.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 21, 2023

US-based biopharmaceutical company Blue Water Vaccines has signed an asset purchase agreement with Veru to buy its Entadfi (finasteride and tadalafil) capsules business, for a total consideration of $100m. The company plans to optimise strategies around sales, distribution and marketing of the drug to increase its access.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .

Packaging 52

Packaging Vaccines Compounding Dosage 52

Fuld

NOVEMBER 1, 2022

Brad is a well-known commercial leader and influencer in the pharmaceuticals industry, especially in the fields of Infectious diseases, Immunology, and Vaccines. During his tenure at top pharmaceutical firms such as Pfizer and Merck, Brad was an integral part of the commercial introduction of blockbuster brands. www.fuld.com.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Roots Analysis

NOVEMBER 6, 2023

In this context, several industry players have demonstrated high inclination towards supporting and advancing the development of next generation RNA-based therapeutics, vaccine and technologies. The below given figure provides an illustrative summary of the benefits of next generation RNA-based vaccines and RNA-based therapeutics market.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Roots Analysis

OCTOBER 30, 2023

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

Vaccines 40

Vaccines Immunization Packaging Pharmaceutical Companies 40

STAT

FEBRUARY 8, 2024

A road test for fresh pharma CEOs A lot can change in five years — including the leadership of the three major pharmaceutical companies that will be testifying before Sen.   Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Bernie Sanders’ HELP Committee today. Read the rest…

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Vaccines 111

pharmaphorum

SEPTEMBER 6, 2022

The NHS is moving to the next phase of its SARS-CoV-2 vaccination programme, following health secretary Steve Barclay’s acceptance of advice from the Joint Committee on Vaccination and Immunisation (JCVI) to go ahead with rollout of Pfizer’s bivalent 30mg booster shot this week. million)” during the first year of vaccinations.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JANUARY 16, 2023

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. However, Merck only produced the vaccine at one of its plants and was not involved in the commercial, more complex part of the manufacturing process at another plant, according to sources close to the matter.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies 111

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 64

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.

Vaccines 52

Vaccines Nursing Homes Pharmaceutical Companies Pharmaceutical Companies 52

STAT

JUNE 22, 2023

Hope you have a smashing day and, of course, do stay in touch … Leaders of European pharmaceutical companies argued that a proposed overhaul of European Union policies could render the industry less competitive, the latest step in their opposition to legislation that could shorten exclusivity periods for selling drugs, STAT writes.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

The Checkup by Singlecare

APRIL 6, 2023

Vaccines have been an essential part of protecting public health for decades. However, despite the overwhelming evidence for their effectiveness and safety, there has been an increasing trend of vaccine hesitancy in recent years. What is vaccine hesitancy? Are there any long-term risks with vaccines?

Vaccines 52

Vaccines Immunization Communication Pharmaceutical Companies 52

pharmaphorum

MARCH 31, 2021

Another recent change is the timelier release of scientific information; rather than holding on to clinical trial findings until the ‘perfect’ opportunity to present them at a major congress, 2020 increasingly saw pharmaceutical companies make data public in real time. Conclusion.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

The Guardian - Pharmaceutical Industry

MARCH 21, 2025

Pharmaceutical company will invest money over five years in strategic partnership with the citys authorities Business live latest updates AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and (..)

Pharmaceutical Companies 63

Pharmaceutical Companies Pharmaceutical Companies Vaccines 63

pharmaphorum

SEPTEMBER 7, 2020

Additionally, it is hard for companies to determine which initiatives they should scale up and which will add most value in the long-term, as often there is a long time before return on investment is generated. This will not only help in the race to finding a vaccine, but in all future medical research. Success in a post COVID-era.

Pharmaceutical Companies 125

Pharmaceutical Companies Pharmaceutical Companies Vaccines 125

Roots Analysis

AUGUST 13, 2024

mRNA-based therapeutics and vaccines have emerged as a promising alternative to conventional treatment approaches. Till date, four mRNA-based vaccines have received approval for the treatment of COVID-19, while a number of such candidates are being evaluated as potential therapies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

STAT

MAY 20, 2024

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing.

Pharmaceutical Companies 140

Pharmaceutical Companies Pharmaceutical Companies Vaccines 140

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Insurance Vaccines 56